Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity. A clinical trial reported a 52% reduction in symptoms and 68% remission, and researchers believe the technology could transform PTSD care.
AI summary · generated only from source feed metadata; consult originalSource published
Published here
views4
Original source
ScienceDaily
Media report · consult original reporting
Read the original ↗https://www.sciencedaily.com/releases/2026/10/261022081309.htmOriginal headline
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
AI bilingual edit · consult originalHeadlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.